Development of the CRISPR-Cas12a system for editing of Pseudomonas aeruginosa phages

Yibao Chen,Bingjie Yan,Weizhong Chen,Xue Zhang,Zhengjie Liu,Qing Zhang,Lulu Li,Ming Hu,Xiaonan Zhao,Xiaohui Xu,Qianghua Lv,Yanbo Luo,Yumei Cai,Yuqing Liu
DOI: https://doi.org/10.1016/j.isci.2024.110210
IF: 5.8
2024-06-06
iScience
Abstract:Pseudomonas aeruginosa is a common opportunistic pathogen. The potential efficacy of phage therapy has attracted the attention of researchers, but efficient gene-editing tools are lacking, limiting the study of their biological properties. Here, we designed a type V CRISPR-Cas12a system for the gene editing of P. aeruginosa phages. We first evaluated the active cutting function of the CRISPR-Cas12a system in vitro and discovered that it had a higher gene-cutting efficiency than the type II CRISPR-Cas9 system in three different P. aeruginosa phages. We also demonstrated the system's ability to precisely edit genes in Escherichia coli phages, Salmonella phages, and P. aeruginosa phages. Using the aforementioned strategies, non-essential P. aeruginosa phage genes can be efficiently deleted, resulting in a reduction of up to 5,215 bp (7.05%). Our study has provided a rapid, efficient, and time-saving tool that accelerates progress in phage engineering.
What problem does this paper attempt to address?